W C S Cho

Summary

Country: China

Publications

  1. ncbi Nasopharyngeal carcinoma: molecular biomarker discovery and progress
    William Chi Shing Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Room 1305, 13 F, Block R, 30 Gascoigne Road, Kowloon, Hong Kong SAR, PR China
    Mol Cancer 6:1. 2007
  2. ncbi Contribution of oncoproteomics to cancer biomarker discovery
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR, PR China
    Mol Cancer 6:25. 2007
  3. ncbi Genomic Sequence Analysis of EGFR Regulation by MicroRNAs in Lung Cancer
    Lawrence Wc Chan
    Room 1305, 13 F, Block R, Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong
    Curr Top Med Chem 12:920-6. 2012
  4. ncbi Exploiting the therapeutic potential of microRNAs in human cancer
    William Cs Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Room 1305, 13 F, Block R, 30 Gascoigne Road, Kowloon, Hong Kong 852 2958 5441 852 2958 5455
    Expert Opin Ther Targets 16:345-50. 2012
  5. ncbi Cancer research on non-small cell lung cancer in smokers and non-smokers: snapshots from the AACR annual meeting 2009
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong
    Cancer Biol Ther 8:1309-12. 2009
  6. ncbi Updates in cancer research: insights from the AACR 100th Annual Meeting
    William C S Cho
    Room 1305, 13 F, Block R, Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong
    Expert Rev Mol Diagn 9:411-6. 2009
  7. ncbi MicroRNAs in cancer - from research to therapy
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR
    Biochim Biophys Acta 1805:209-17. 2010
  8. ncbi MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong
    Int J Biochem Cell Biol 42:1273-81. 2010
  9. ncbi Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
    W C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong
    Br J Cancer 102:1731-5. 2010
  10. ncbi Scientific evidence on the supportive cancer care with Chinese medicine
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR
    Zhongguo Fei Ai Za Zhi 13:190-4. 2010

Collaborators

Detail Information

Publications27

  1. ncbi Nasopharyngeal carcinoma: molecular biomarker discovery and progress
    William Chi Shing Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Room 1305, 13 F, Block R, 30 Gascoigne Road, Kowloon, Hong Kong SAR, PR China
    Mol Cancer 6:1. 2007
    ..In this article, the latest molecular biomarker discovery and progress in NPC is reviewed with respect to the diagnosis, monitoring, treatment and prognostication of the disease...
  2. ncbi Contribution of oncoproteomics to cancer biomarker discovery
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR, PR China
    Mol Cancer 6:25. 2007
    ....
  3. ncbi Genomic Sequence Analysis of EGFR Regulation by MicroRNAs in Lung Cancer
    Lawrence Wc Chan
    Room 1305, 13 F, Block R, Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong
    Curr Top Med Chem 12:920-6. 2012
    ..This new strategy that integrates computational and published data approaches provides a fast and effective prediction of miRNAs in specific target genes involved in various diseases...
  4. ncbi Exploiting the therapeutic potential of microRNAs in human cancer
    William Cs Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Room 1305, 13 F, Block R, 30 Gascoigne Road, Kowloon, Hong Kong 852 2958 5441 852 2958 5455
    Expert Opin Ther Targets 16:345-50. 2012
    ..Nevertheless, new findings from recent studies and the rapid advances in systemic drug delivery systems provide an optimistic perspective on the evolution of the field...
  5. ncbi Cancer research on non-small cell lung cancer in smokers and non-smokers: snapshots from the AACR annual meeting 2009
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong
    Cancer Biol Ther 8:1309-12. 2009
    ..This meeting report aims to provide the readers with a summary of the research highlights on NSCLC in smokers and non-smokers presented in the AACR annual meeting 2009...
  6. ncbi Updates in cancer research: insights from the AACR 100th Annual Meeting
    William C S Cho
    Room 1305, 13 F, Block R, Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong
    Expert Rev Mol Diagn 9:411-6. 2009
    ..These and other important presentations from the AACR Annual Meeting 2009 are discussed in this article, which intends to provide updates on the cancer research presented in the most important cancer research meeting in the world...
  7. ncbi MicroRNAs in cancer - from research to therapy
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR
    Biochim Biophys Acta 1805:209-17. 2010
    ..Here the latest findings of which genes are targeted by each miRNA are reviewed, with particular emphasis on the deciphering of their possible mechanisms and the potential of miRNA-based cancer therapeutics...
  8. ncbi MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong
    Int J Biochem Cell Biol 42:1273-81. 2010
    ....
  9. ncbi Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
    W C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong
    Br J Cancer 102:1731-5. 2010
    ....
  10. ncbi Scientific evidence on the supportive cancer care with Chinese medicine
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR
    Zhongguo Fei Ai Za Zhi 13:190-4. 2010
    ....
  11. ncbi Conquering cancer through discovery research
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong
    IUBMB Life 62:655-9. 2010
    ..With highlights on the most up-to-date molecular, cellular, clinical, and therapeutic cancer research findings, this article tends to provide a wealth of insights into better understanding of the complexity of cancer...
  12. ncbi The role of inflammation in the pathogenesis of lung cancer
    William Cs Cho
    Queen Elizabeth Hospital, Department of Clinical Oncology, Kowloon, Hong Kong
    Expert Opin Ther Targets 15:1127-37. 2011
    ..Along with therapeutic benefits, immunotherapy presents the challenges of drug-related toxicities. Gene modification of immunocytokine may lower the associated toxic effects...
  13. ncbi Epigenetic alteration of microRNAs in feces of colorectal cancer and its clinical significance
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Room 1305, 13 F, Block R, 30 Gascoigne Road, Kowloon, Hong Kong
    Expert Rev Mol Diagn 11:691-4. 2011
    ..This article evaluates a recently published study investigating the usefulness of epigenetically silenced miRNAs in fecal specimens, including miR-34b/c and miR-148a, as potential markers for CRC screening and prognosis...
  14. ncbi Proteome profiling for the identification of lung cancer signatures
    William Cs Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Room 1305, 13 F, Block R, 30 Gascoigne Road, Kowloon, Hong Kong
    Expert Rev Proteomics 8:689-92. 2011
    ....
  15. ncbi Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation
    William C S Cho
    Department of Clinical Oncology, Room 1305, 3 F, Block R, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong
    Eur J Cancer 45:2197-206. 2009
    ..The present study focuses on the microRNA (miRNA) expression profiles of this important subset of lung cancer...
  16. ncbi Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis
    William Cs Cho
    Queen Elizabeth Hospital, Department of Clinical Oncology, Room 1305, 13 F, Block R, 30 Gascoigne Road, Kowloon, Hong Kong
    Expert Opin Investig Drugs 18:617-35. 2009
    ..This study aims to systemically review the efficacy of Chinese herbal therapy in HCC patients receiving TACE...
  17. ncbi Clinical efficacy of traditional Chinese medicine as a concomitant therapy for nasopharyngeal carcinoma: a systematic review and meta-analysis
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China
    Cancer Invest 27:334-44. 2009
    ..There were 16 Chinese herbs found to be commonly used across the studies. Published studies suggest that TCM is efficacious as a concomitant therapy for NPC patients. These results require confirmation with rigorously controlled trials...
  18. ncbi [Progress of treatment for bladder cancer]
    William Chi-Shing Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China
    Zhong Xi Yi Jie He Xue Bao 5:85-91. 2007
  19. ncbi In vitro and in vivo anti-tumor effects of Astragalus membranaceus
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, People s Republic of China
    Cancer Lett 252:43-54. 2007
    ..Collectively, the results showed that A. membranaceus could exhibit both in vitro and in vivo anti-tumor effects, which might be achieved through activating the anti-tumor immune mechanism of the host...
  20. ncbi Oncoproteomics: current trends and future perspectives
    William C S Cho
    Queen Elizabeth Hospital, Department of Clinical Oncology, Kowloon, Hong Kong SAR, PR China
    Expert Rev Proteomics 4:401-10. 2007
    ..In this review, the development and advancement of oncoproteomics technologies for cancer research in recent years are expounded...
  21. ncbi In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus
    William Chi Shing Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, SAR, China
    J Ethnopharmacol 113:132-41. 2007
    ..Collectively, the results clearly showed that AI could exhibit immunomodulating and immunorestorative effects, both in vitro and in vivo...
  22. ncbi A future of cancer prevention and cures: highlights of the Centennial Meeting of the American Association for Cancer Research
    W C Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, PR China
    Ann Oncol 19:205-11. 2008
    ..For those who did not attend the meeting, this report may serve as a highlight of this important international cancer research meeting...
  23. ncbi Proteomics technologies and challenges
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China
    Genomics Proteomics Bioinformatics 5:77-85. 2007
    ..Nevertheless, proteomics is the foundation for constructing and extracting useful knowledge to biomedical research. In this review, a snapshot of contemporary issues in proteomics technologies is discussed...
  24. ncbi OncomiRs: the discovery and progress of microRNAs in cancers
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Room 1305, 13 F, Block R, 30 Gascoigne Road, Kowloon, Hong Kong SAR, PR China
    Mol Cancer 6:60. 2007
    ..The paper ends with a brief perspective to the future of oncomiRs...
  25. ncbi Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer
    William Chi Shing Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Room 1305, 13 F, Block R, 30 Gascoigne Road, Hong Kong
    Biomed Pharmacother 61:515-9. 2007
    ..It is intended for policy makers, researchers, clinicians and other health professionals, offering a variety of useful biomarkers and updated data of clinical trials for lung cancer...
  26. ncbi Application of proteomics in Chinese medicine research
    William Chi Shing Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, PR China
    Am J Chin Med 35:911-22. 2007
    ....
  27. ncbi Latest discoveries and trends in translational cancer research: highlights of the 2008 Annual Meeting of the American Association for Cancer Research
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, PR China
    Technol Cancer Res Treat 7:269-77. 2008
    ..For those who did not attend the meeting, this report may serve as a highlight of this important international cancer research meeting...